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The growth response ofnormal and humanpap-
ilomavirus (HPV)-transformed cervical kerati-
nocytes to interferon-y (IFN-,y) and tumor necro-
sis factor-a was investigated in monolayer and
organotypic raft cultures. Theproliferation rates
ofmonolayer cultures were assessed by [3HJTdR
incorporation andfluorimetric DNA titration. The
growth of keratinocytes in organotypic cultures
was estimated by their ability to stratify on col-
lagen rafts and by immunohistochemistry for
Ki67 antigen expression. IFN-,y reduced the DNA
synthesis ofnormal and HPV-transformed kera-
tinocytes in monolayer cultures and exerted a
marked growth inhibitory effect in organotypic
raft cultures. In control raft cultures, normal ke-
ratinocytes produced an epithelial sheet of ap-
proximately 10 ceUs in tbickness that closely re-
sembled normal cervical epithelium and was
characterized by sparse Ki67 antigen-positive
ceUls whereas HPV-transformed keratinocytes
producedup to 15poorly differentiatedepithelial
layers that were reminiscent of high grade cer-
vical lesions seen in vivo and exhibited a fuU
thickness Ki67 antigen expression. When normal
and HPV-transformed keratinocytes were main-
tained in the presence of IFN-'y, the epithelial
sheet was reduced to afew ceUls in thickness and
the density ofKi67 antigen-positive ceUs was de-
creased. A morepronouncedgrowth inhibitory ef-
fect in monolayer and organotypic cultures was
observed when IFN-,y was associated with tumor
necrosisfactor-ax Tumor necrosisfactor-a alone
reduced the DNA syntbesis of normal keratino-
cytes but was significantly less effective than
IFN-,y to inhibit the growth ofHPV-transformed
keratinocytes. These results suggest that similar
responses in vivo to regulatory molecules may
play a role in the development ofHPV-related le-
sions. (AmJ Pathol 1995, 146:589-598)
Evidence supporting the concept that human papil-
lomavirus (HPV) is an essential factor in the devel-
opment of cervical cancers has been demonstrated
by numerous studies. HPV DNA, in particular, HPV-
16, -18 and -33, is detected in more than 90% of cer-
vical cancer biopsies1' 2 and has been shown to ef-
ficiently immortalize human foreskin and cervical
keratinocytes in tissue culture.-5 HPV by itself, how-
ever, does not appear to be able to induce malignant
transformation. In vitro studies examining the capac-
ity of HPV DNA to transform primary cells in culture
illustrate that HPV must act in concert with secondary
cellular or host factors, such as the activated onco-
genes Ha-ras to achieve the fully transformed phe-
notype.6'7 In this context, the general or local immune
state might be expected to have a key role in host
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defense against HPV infection and the possible de-
velopment of cervical carcinoma. Several studies
have described a localized immune dysfunction ac-
companying cervical HPV infection. Specifically, al-
terations in the numbers of Langerhans cells and T
helper lymphocytes have been reported in HPV-
related disease.8-10 On the other hand, regression of
HPV-induced lesions is accompanied by a local in-
filtration of inflammatory cells including macro-
phages, cytotoxic T lymphocytes, and natural killer
cells.11-13 It is likelythatthese cells produce avariety
of cytokines that are critical components of the host
response to infection or injury. HPV-transformed cer-
vical keratinocytes have also been demonstrated to
produce reduced levels of cytokines comparable with
normal cervical cells.14 The decrease in local cyto-
kine production or the loss of responsiveness to cy-
tokines by immunocompetent cells or keratinocytes
might represent two potential mechanisms by which
the infected cell escapes destruction by the host's
immune system.
Interferon-y (IFN-y) and tumor necrosis factor-a
(TNF-a) are regulatory cytokines with pleiotropic bio-
logical activities including antiproliferative, antiviral,
and immunomodulatory activities.15-17 They are ca-
pable of modulating the expression of cell surface
molecules, eg, HLA class 11 antigens and intercellular
adhesion molecules, with a pivotal role in the inter-
action of neoplastic or infected cells with the host's
immune system.17
The development of a model system for studying
molecular mechanisms by which cytokines or other
host factors regulate the proliferation and differentia-
tion of HPV-infected cells has been hampered by the
lack of both a permissive tissue culture system for
viral propagation as well as an easy method for grow-
ing normal stratified epithelium in vitro. HPV-
immortalized keratinocytes as well as cervical carci-
noma cell lines have been shown to represent a
convenient and bona fide in vitro counterpart to pre-
malignant and malignant cells that arise in vivo as a
result of HPV DNA integration and expression of the
viral E6/E7 oncogenes.3-5,18 Most characteristics of
preneoplastic and neoplastic cells, however, require
the context of epithelial tissue architecture to be iden-
tified as such.
In this study, we examined the effect of IFN-y and
TNF-a on the growth of HPV-transformed keratino-
cytes in monolayer and organotypic cultures. The raft
technique allows cells to proliferate and differentiate
at an air-liquid interface on a dermal equivalent sup-
port. Normal keratinocytes stratify and fully differen-
tiate in a manner similar to the normal squamous epi-
thelial tissues whereas HPV-immortalized (after many
passages) and established squamous carcinoma
cell lines exhibit dysplastic morphologies similar to
high grade lesions seen in vivo.19-22
Materials and Methods
Culture of Normal Cervical Keratinocytes
Cultures of normal cervical keratinocytes were estab-
lished from hysterectomy specimens. The operations
were performed for diseases unrelated to the cervix.
Cell cultures were established and maintained follow-
ing a previously described protocol.5 Cultures were
maintained at 37 C and medium was changed every
2 to 3 days. The medium was a 1:3 mixture of HAM
F12 (GIBCO BRL, Gaithersburg, MO)/Dulbecco's
modified Eagle's medium (GIBCO BRL), supple-
mented with 0.5 pg/ml hydrocortisone (Sigma Chemi-
cal Co., St. Louis, MO), 10 ng/ml epidermal growth
factor (Sigma), 10% decomplemented fetal calf se-
rum (Life Sciences International, Zellik, Belgium), 1%
L-glutamine 200 mmol/L (GIBCO BRL), 10 mmol/L
HEPES (GIBCO BRL), 1 pg/mI fungizone (GIBCO
BRL), 1 mmol/L sodium pyruvate (GIBCO BRL),
3000 U/ml penicillin-streptomycin (GIBCO BRL),
10 -10 mol/L cholera toxin (Sigma), 5 pg/ml insulin
(Sigma), 20 pg/mI adenine (Sigma), 5 pg/ml human
transferrin (Sigma), 15 x 10-4 pg/ml 3,3',5-triiodo-L-
thyronine (Sigma).
HPV-Transformed Keratinocyte Cell Lines
The CK2 cell line was established by transfection of
human cervical keratinocytes with HPV 33 DNA and
did not form tumors when injected into nude mice.
The derivation and characterization of this cell line
have been described in detail.5 CK2 cells that were
used for clonal growth experiments performed in this
study originated from cultures that were grown in vitro
for more than 100 passages. The SiHa and Caski cell
lines are tumorigenic cervical carcinoma-derived ker-
atinocyte cell lines that contain, respectively, 1 and
approximately 600 copies of integrated HPV-16
DNA.2324 Two cell lines (supplied by Dr. J. K. Mc-
Dougall) established by transfection of human fore-
skin keratinocytes with HPV-16 DNA (EIL8; nontumori-
genic) or HPV-18 DNA (18-1 1S3; tumorigenic after 60
passages in tissue culture) were also tested for re-
sponse to IFN-y and/or TNF-a.21
Cytokines
Human recombinant IFN-y (2 x 107 U/mg) and re-
combinant TNF-a (4.9 x 107 U/mg) were kindly pro-
vided by Boehringer Ingelheim (Brussels, Belgium).
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Cell Proliferation Assays
The growth response of cells to cytokines in mono-
layer cultures was assessed by [3H]TdR incorpora-
tion and fluorimetric DNA titration. Evaluation of [3H]-
TdR uptake by keratinocytes was performed by using
protocols previously described.25 Cells were seeded
onto flat bottom 96-well tissue culture plates (Falcon;
Becton, Dickinson Labware, Lincoln Park, NJ) at a
density of 5 x 103 cells/well in 200 pl of culture me-
dium and allowed to attach overnight. The medium
was then supplemented with 100 to 10,000 U/mI re-
combinant IFN-y, TNF-a, and IFN-y in combination
with TNF-a. Three different times of incubation with
the cytokines were tested (24, 48, and 72 hours), and
0.4 pCi of [3H]TdR (Amersham, Arlington Heights, IL)
was added simultaneously with the cytokines or after
24 and 48 hours, followed by incubation for another
24 hours. The cells were then lysed with NaOH and
harvested onto glass-fiber filters with an automatic
cell harvester, and the radioactivity retained on the
filters was measured in a liquid scintillation counter.
Each experiment was done in triplicate and mean
cpm values were taken for calculations.
For fluorimetric DNA titration, keratinocytes were
seeded into 24-well plates (Nunc; GIBCO BRL) at a
density of 25 x 103 cells/2 ml/well. After overnight
culture and addition of cytokines, cells were har-
vested (after 24,48, and 72 hours of culture) and soni-
cated in phosphate-buffered saline. Fluorimetric DNA
titration was performed on sonicated cells following
the method described by Labarca and Paigen26 and
used as an indicator of cell density.
Organotypic Cultures
Organotypic cultures of normal cervical keratinocytes
and HPV-transformed cell lines (CK2 and SiHa) were
generated by procedures slightly modified from those
described previously. 19-22 Dermal equivalents were
produced according to the manufacturer's instruc-
tions (Collagen Corp., Palo Alto, CA). Briefly, 8 ml of
Vitrogen 100 collagen was mixed on ice with 1 ml of
chilled 1OX concentrated Hanks' balanced salt solu-
tion supplemented with phenol red and 1 N NaOH to
obtain a pH of approximately 7.2 and 105 normal hu-
man fibroblasts in 1 ml of decomplemented fetal calf
serum (Tech-Gen). One milliliter of the gel solution
was then layered onto 24-well plates (Falcon) and al-
lowed to solidify at 37 C for 2 to 4 hours. After gel
equilibration with 1 ml of Dulbecco's modified Eagle's
medium at 37 C overnight, 25 x 104 to 30 x 104 ke-
ratinocytes suspended in 1 ml of growth medium were
seeded on top of the gels and maintained submerged
for 3 to 4 days. Rafts were then raised onto a stainless
metal grid and allowed to grow at the air-liquid inter-
face for 10 to 14 days. Medium supplemented or not
with either IFN-y (1000 U/ml), TNF-a (1000 U/ml), or
IFN-y (1000 U/ml) in combination with TNF-a (1000
U/ml) was changed every 2 to 3 days. Organotypic
cultures then were fixed in 10% neutral buffered form-
aldehyde or 3% paraformaldehyde, embedded in
paraffin or plastic (JB4), sectioned, and stained with
hematoxylin and eosin (H&E) or immunolabeled with
the MIB-1 monoclonal antibody specific for Ki-67 an-
tigen (Immunotech S.A.). Reversibility was examined,
in monolayer and organotypic cultures, 72 hours after
removal of cytokines.
Ki-67 Antigen Immunostaining
Five-micron sections of the raft specimens were
deparaffinized, rehydrated, and incubated with
0.05% trypsin (GIBCO BRL) in Tris-buffered saline
(TBS) for 20 minutes at 37 C. After enzyme digestion,
slides were rinsed in TBS. Antigen retrieval was then
performed by treating the slides for 15 minutes at 720
W in citrate buffer (10 mmol/L; pH 6.0) in a microwave
oven. After washing in TBS, sections were blocked
with normal rabbit serum for 30 minutes and incu-
bated at room temperature for 60 minutes with the
MIB-1 monoclonal antibody specific for Ki-67 antigen
(Immunotech S.A., Marseille, France) diluted 1:100 in
TBS. The slides were then washed in TBS and incu-
bated at room temperature for 30 minutes with a bi-
otinylated rabbit anti-mouse monoclonal antibody (1:
200; Dako, Carpenteria, CA). After another washing
step, localization of the antibodies was performed by
using the avidin-biotin complex method with alkaline
phosphatase as enzyme and new fuschin (Dako-
patts) as chromogen. The sections were finally coun-




The evaluation of Ki-67 antigen immunostaining in or-
ganotypic cultures was based on the density of posi-
tive cells assessed by counting the number of stained
nuclei in the reconstituted epithelium, the area of
which was estimated with a computerized system of
image analysis (IBAS) following a method previously
described.27 Briefly, areas of reconstituted epithelium
were traced on the video screen and numbers of posi-
tively stained nuclei were calculated per 0.1 mm2 of
epithelium, based on at least three fields of view at
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x100 magnification. The percentage of Ki-67
antigen-positive cells was also evaluated by the fol-
lowing method. Nuclei from a minimum of 100 cells
per section across the full epithelial thickness were
assessed in triplicate and the means taken. Positive
nuclei were expressed as a percentage of the total
nuclei counted. Standard deviation from the mean
was calculated in all cases and statistical analysis
was performed by using the Student's t-test.
Results
Effect of IFN-y and TNF-a on Normal and
HPV-Transformed Keratinocytes in
Monolayer Cultures
IFN-y reduced, in a time- and dose-dependent man-
ner, the DNA synthesis of normal and HPV-
transformed keratinocytes growing in monolayer cul-
tures. The fluorimetric DNA titration (data not shown)
and [3H]TdR incorporation analysis (Figure 1) gave
similar results although a slightly more pronounced
effect resulting in a higher percentage of inhibition
was observed with the [3H]TdR incorporation analy-
sis. TNF-a reduced the DNA synthesis of normal ke-
ratinocytes but was significantly less effective than
IFN-y to inhibit the growth of HPV-transformed kera-
tinocytes (72 hours of cytokines (100 to 1000 U/ml);
P < 0.05 by Student's t-test; Figure 1). Normal kera-
tinocytes were found to be generally more sensitive
than HPV-transformed keratinocytes to the growth in-
hibitory effect of TNF-a, although statistically signifi-
cant differences were obtained only when comparing
normal keratinocytes to three HPV-positive cell lines
(CK2, SiHa, and 18-1 1S3; P< 0.05). A broader range
of sensitivities of HPV-transformed keratinocytes to
TNF-a was also observed than had been noted with
IFN-y. The inhibition of growth was maximal after 72
hours of treatment with IFN-y combined with TNF-a
(Figure 1). The combination of IFN-y and TNF-a (1000
U/ml) exerted statistically significant higher antipro-
liferative effects than TNF-a on both normal and HPV-
transformed keratinocytes (P < 0.05) whereas the
growth inhibitory effect of the combination of IFN-y
and TNF-a (1000 U/ml) was found to be significantly
higher than that of IFN-y only on the HPV-transformed
SiHa, Caski, and 18-11S3 cell lines (P < 0.05). A
marked tendency to reversibility was observed 72
hours after removal of cytokines from cultures of nor-
mal keratinocytes treated by IFN-y and/or TN F-a and
from most of the HPV-transformed keratinocyte cell
lines treated by TNF-a. A partial reversibility was ob-
served only for two HPV-positive cell lines treated by
IFN-y and IFN-y with TNF-a (CK2 and SiHa).
Effect of IFN-y and TNF-a on Normal and
HPV-Transformed Keratinocytes in
Organotypic Cultures
Similar inhibitory effects of cytokines were observed
in organotypic cultures. Normal keratinocytes and
two HPV-transformed cell lines (CK2 and SiHa) were
chosen to illustrate these effects. In the absence of
cytokines, normal keratinocytes produced differenti-
ated epithelial layers of approximately 10 cells in
thickness (Figure 2A, B) that were characterized by
sparse Ki-67 antigen-positive cells whereas HPV-
transformed keratinocytes produced an epithelial
sheet of up to 10 to 15 cells in thickness. These cells
appeared disorganized and highly atypical through-
out its full thickness, reminiscent of high grade cer-
vical lesions (Figure 2D, E). There was also expres-
sion of Ki-67 antigen throughout the full thickness of
the epithelium, as already observed in biopsy speci-
mens of grade 3 cervical intraepithelial neoplasia
(manuscript in preparation) (Figure 2G, H). The
growth of normal keratinocytes in organotypic cul-
tures was inhibited by IFN-y, TNF-a, and IFN-y com-
bined with TNF-a. This antiproliferative effect of cy-
tokines was reflected by the impairment of normal
epithelial stratification, which was reduced to a few
cells in thickness (Figure 2C). The comparison of
Ki-67 antigen immunostaining between control and
cytokine-treated organotypic cultures of normal ke-
ratinocytes was not possible because of the presence
of rare positive cells in both conditions. The stratifi-
cation and immunostaining for Ki-67 antigen of HPV-
transformed keratinocytes were dramatically de-
creased in the presence of IFN-y and IFN-y combined
with TNF-a (Figure 2F-I). The epithelial layer was re-
duced to a few cells in thickness and the density (or
percentage) of Ki-67 antigen-positive cells was sig-
nificantly lower than that of untreated cultures (Table
1). A more pronounced effect was also observed with
the combination of IFN-y and TNF-a. This effect
tended to become partially reversible within 72 hours
after removal of cytokines. TNF-a alone, at a concen-
tration of 1000 U/ml, did not hamper significantly the
stratification/proliferation of the HPV-transformed
CK2 and SiHa cell lines.
Discussion
The long latency period between initial HPV infection
and the development of cervical cancer and the high
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Figure 1. Effect ofIFN-,y (A and D), TNF-a (B and E), and IFN-,y plus 7N7F-a (C and F) on DNA synthesis of normal and HPV-transformed kera-
tinocytes (P3H]TdR incorporation). 7Tree different times of incubation with the cytokines (1000 U/ml) were tested (24, 48, and 72 hours after cyto-
kine addition) and reversibility was examined 72 hours after removal of cytokines (A to C). The effect of different concentrations ofcytokines was
also analyzed after 72 hours of incubation (D to F). 7Te results are expressed as percentages of control values. The standard deviations did not
exceed 10%. *, normal keratinocytes; *, CK2; A, SiHa; El, Caski; O, EIL8; A, 18-11S3.
frequency of premalignant cervical lesions compared
with that of invasive carcinoma suggest that other fac-
tors in addition to HPV infection are required for
tumorigenicity. One way in which preneoplastic HPV-
transformed keratinocytes could acquire a prolifera-
tive advantage is by escaping negative forms of
growth control, exerted by, eg, some cytokines. The
abrogation of this growth control could result from a
decreased production of cytokines by immunocom-
petent cells or keratinocytes in HPV infections or from
an increased resistance to their effects.
In this study, we have shown that normal human
cervical keratinocytes are sensitive to the growth in-
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Table 1. Effect ofIFN-y, TNF-a and IFN-,y Combined with
TNF-a on the Density (or Percentage) ofKi-67
Antigen-Positive cells in Sections of Organotypic
Cultures of the HPV-Transformed Cell Lines CK2
and SiHa
Cell IFN-y +
lines Control IFN-y TNF-a TNF-a
CK2 188 (74%) 99 (39%)* 177 (70%) 95 (34%)*
SiHa 249 (96%) 171 (59%)* 246 (94%) 104 (55%)*
The density and percentage of Ki-67 antigen-positive cells are
expressed, respectively, as the number of positive cells per 0.1
mm2 and the number of positive cells per 100 cells counted.
*Density (percentage) of positive cells significantly decreased
(P < 0.05) as compared with untreated control cultures.
congruent with previous reports that utilized single-
cell suspensions of normal skin and other proliferation
assays.2829 We demonstrated that HPV-transformed
keratinocytes did not lose their sensitivity to the an-
tiproliferative effect of IFN-y, compared with normal
keratinocytes. These results associated with the dem-
onstration of a localized immunodepletion in HPV-
related lesions suggest that recombinant IFN-y might
be effective as a therapeutic agent in the treatment of
cervical HPV infections. Tay et al10 reported a deple-
tion of T lymphocytes (predominantly of CD4+ phe-
notype) in all grades of HPV-associated lesions. This
depletion of T helper (TH) lymphocytes might be re-
sponsible for a decreased local production of IFN-y.
A preferential differentiation of these TH lymphocytes
into the TH2 versus the TH1 phenotype, which can be
observed in conditions in which the interleukin-12
produced by the monocyte-macrophages and other
accessory cells such as Langerhans cells is re-
duced,3031 might still reduce the local secretion of
IFN-y. The administration of recombinant IFN-y might
overcome this local depletion of IFN-y and restore a
putative mechanism of negative growth control of
HPV-transformed keratinocytes. The nature of HPV-
induced cervical lesions has made IFN-y a logical
therapeutic approach, and several studies have al-
ready reported complete or partial remissions of cer-
vical and other genital HPV-related lesions after topi-
cal or perilesional treatment with IFN-y.12'32'33
Whether this response in vivo is due to the antipro-
liferative effect of IFN-y, to its antiviral activity, or to its
immunomodulatory functions is unknown, although it
is probable that all of these properties of IFN-y play
a role, to varying degrees, in limiting the HPV-related
disease. Interestingly, IFN-y has been shown to inhibit
HPV gene transcription34'35 and to up-regulate the
expression of intercellular adhesion molecule-1
(ICAM-1) in HPV-transformed keratinocytes.22
An important finding of this study is that IFN-y in-
hibited the growth of HPV-positive keratinocytes
grown on collagen rafts as well as in monolayer cul-
tures. The ability of IFN-y to directly inhibit prolifera-
tion of HPV-positive keratinocytes, even under culture
conditions that mimic physiological conditions to
some extent, suggests that this cytokine might also
regulate the growth of HPV-associated lesions in vivo.
The effect of IFN-y in the organotypic culture system
was reflected by the failure of these cervical kerati-
nocytes to stratify on a collagen raft and to reproduce
a proliferative epithelium, reminiscent of high grade
cervical lesions. This altered stratification of HPV-
transformed keratinocytes in the presence of IFN-y
was also associated with a decreased density of
Ki-67 antigen-positive cells. The Ki-67 antigen is a cell
cycle and tumor growth marker that is present
throughout the cell cycle (G1, S, G2, and M phases)
of proliferating cells and absent in quiescent (GO)
cells.36 Several studies have shown that there is a
good relationship between detectable expression of
Ki-67 and growth fraction in several model systems
and that the Ki-67 labeling index is a marker of prog-
nostic relevance in the study of human tumors.37-3
The function of Ki-67 remains unclear, but it may rep-
resent a structural protein that maintains the higher
order structure of DNA during the important events of
mitosis.40
Although there was no histological evidence of in-
creased squamous differentiation in the organotypic
cultures of HPV-transformed keratinocytes treated by
IFN-y and/or TNF-a, we performed immunohisto-
chemical studies with anti-involucrin and anti-keratin
10 antibodies, which are considered as markers for
keratinization.41 42 The comparison between control
and cytokine-treated organotypic cultures did not
show any significant difference in the expression of
these markers. There was no staining or only a slight
reactivity for involucrin and keratin 10 in both control
and cytokine-treated cultures (unpublished results).
This staining pattern is similar to that previously ob-
served in high grade cervical intraepithelial le-
sions.41,42
Figure 1. A to F: Plastic-embedded H&E-stained sections. A: Biopsy specimen of normal exocervical epithelium. B: Organotypic culture of normal
cervical keratinocytes in the absence of cytokines. C: Organotypic culture of normal cervical keratinocytes in the presence ofIFN-y associated with
TNF-a. D: Biopsy specimen of high grade cervical lesion, positivefor HPV 16 DNA by in situ hybridization. E: Organotypic culture ofSiHa cells in
the absence of cytokines. F: Organotypic culture of SiHa cells in the presence of IFN-y plus TNF-a. G to 1: Paraffin-embedded Ki67 antigen-
immunostained sections. G: Biopsy specimen of high grade cervical lesion, positive for HPV 16 DNA by in situ hybridization. H: Organotypic cul-
ture of SiHa cells in the absence of cytokines. 1: Organotypic culture of SiHa cells in the presence of IFN- y plus TNF-a. Magnification in A to 1,
X 250.
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TNF-a has been demonstrated to exert antiprolif-
erative effects on a variety of epithelial cell lines in-
cluding HPV-positive keratinocyte cell lines derived
from vulvar bowenoid papules (SK-v)25 or cervical
carcinoma (HeLa, ME-180).4344 An increased resis-
tance to the antiproliferative effect of TNF-a has been
reported in HPV-transformed cell lines with a more
aggressive phenotype29'45 and related to a de-
creased expression of TNF-a receptors.45 In the
present study, normal keratinocytes were found to be
generally more sensitive than HPV-transformed kera-
tinocytes to the growth inhibitory effect of TNF-a. This
partial loss of sensitivity of HPV-transformed kerati-
nocytes to TNF-a might be associated with a de-
creased expression or affinity of TNF-a receptors, as
already demonstrated for keratinocyte and nonkera-
tinocyte cell lines.45'7 In this study, TNF-a was less
efficient than IFN-y in inhibiting the growth of HPV-
transformed keratinocytes.
A more pronounced growth inhibitory effect in
monolayer and organotypic cultures was observed
when IFN-y was combined with TNF-a. Similar inter-
actions between IFN-y and TNF-a have already been
reported in studies analyzing growth of different tumor
cell lines in vitro48-51 and human breast and bowel
tumor xenografts in vivo.52 Synergistic immunomodu-
latory effects have also been described with combi-
nations of IFN-y and TNF-a.53 The induction of re-
ceptors for TNF-a by IFN-y has been proposed to play
a role in their synergistic biological response.54 On
the other hand, it has been shown that TNF-a up-
regulates IFN-y receptor protein expression and
IFN-y receptor mRNA levels in a human colorectal
carcinoma cell line, in which IFN-y and TNF-a exert
synergistic growth inhibitory effects.55
In conclusion, monolayer and organotypic cultures
of HPV-transformed keratinocytes represent useful in
vitro models for studying the importance of host fac-
tors in regulating the growth of HPV-related preneo-
plastic and neoplastic cervical lesions. Such studies
may be of potential interest for the design of new
therapeutic modalities to overcome the local immu-
nodeficiency associated with the development of cer-
vical cancer.
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